[O-46] Oral Session 46 Clinical trial and Regenerative medicine3

[O-46-2] Development of novel classification method to promote new drug development for ALS

^○Yuko Kobayakawa^1,2, Koji Todaka², Yu Hashimoto¹, Ryo Yamasaki¹, Jun-ichi Kira^3,4,5 (1.Department of Neurology neurological Institute, Graduate school of Medicine, Kyushu University, Japan, 2.Kyushu University, Center for Clinical and Translational Research, Japan, 3.Translational Neuroscience Center, Graduate School of Medicine, International University of Health and Welfare, 4.School of Pharmacy at Fukuoka, International University of Health and Welfare, 5.Department of Neurology, Brain and Nerve Center, Fukuoka Central Hospital, International University of Health and Welfare,)